Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06667726
What this trial is testing

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Who this might be right for
Malignant Brain Neoplasm
Mayo Clinic 47
Testing effectiveness (Phase 2)Study completedNCT04125693
What this trial is testing

Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety

Who this might be right for
Cancer
Bayer 1
Not applicableTemporarily Not AvailableNCT06980506
What this trial is testing

MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Who this might be right for
CancerSolid TumorSolid Tumor, Adult
Monopar Therapeutics
Early research (Phase 1)Looking for participantsNCT07619287
What this trial is testing

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies

Who this might be right for
Myeloid Malignancy
BeOne Medicines 118
Not applicableNo Longer AvailableNCT01260779
What this trial is testing

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Who this might be right for
Cutaneous or Subcutaneous Tumors Where There is no Comparable or SatisfactoryApproved Alternative Therapy
Provectus Biopharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00439296
What this trial is testing

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Who this might be right for
Recurrent Pediatric ALLRelapsed Pediatric ALLAcute Lymphoblastic Leukemia+1 more
Therapeutic Advances in Childhood Leukemia Consortium 9
Early research (Phase 1)Looking for participantsNCT06265688
What this trial is testing

First In Human Study of CX-2051 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
CytomX Therapeutics 160
Post-approval studies (Phase 4)Study completedNCT02869789
What this trial is testing

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Who this might be right for
Lung Cancer
Bristol-Myers Squibb 1,041
Large-scale testing (Phase 3)Active Not RecruitingNCT05063552
What this trial is testing

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03662659
What this trial is testing

An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers

Who this might be right for
Gastric CancerCancer of the StomachEsophagogastric Junction
Bristol-Myers Squibb 274
Testing effectiveness (Phase 2)Looking for participantsNCT05562830
What this trial is testing

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

Who this might be right for
Urothelial Carcinoma
Merck Sharp & Dohme LLC 48
Testing effectiveness (Phase 2)Study completedNCT02737475
What this trial is testing

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 166
Testing effectiveness (Phase 2)Looking for participantsNCT05558904
What this trial is testing

An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

Who this might be right for
Lung Adenocarcinoma
Jonsson Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT01306058
What this trial is testing

Sorafenib and TRC105 in Hepatocellular Cancer

Who this might be right for
HepatomaLiver NeoplasmsAdenoma, Liver Cell+2 more
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT06505538
What this trial is testing

Nurse-Led Mobile App Effect on Symptom Management for Breast Cancer Patients After Surgery

Who this might be right for
Symptom ManagementBreast Care NurseMobile App+1 more
Gümüşhane Universıty 45
Testing effectiveness (Phase 2)Ended earlyNCT03013491
What this trial is testing

PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
CytomX Therapeutics 196
Not applicableLooking for participantsNCT04723316
What this trial is testing

Tumour Characterisation to Guide Experimental Targeted Therapy - National

Who this might be right for
Cancer
The Christie NHS Foundation Trust 6,000
Testing effectiveness (Phase 2)Looking for participantsNCT07147348
What this trial is testing

A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 375
Testing effectiveness (Phase 2)Looking for participantsNCT06447103
What this trial is testing

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer+2 more
Jonsson Comprehensive Cancer Center 91
Not applicableNot Yet RecruitingNCT06467331
What this trial is testing

The Effect of Hippotherapy on The Development of Life Satisfaction, Health Literacy and Healthism Attitude of Young Adults After Cancer Treatment

Who this might be right for
CancerNursingHippotherapy+1 more
Betül Çakmak 40
Next Page
430